I have summerized information about new plant from annual report 2023.
There is no mention about delay in new palnt
Kindly provide supporting document.
Thanks
Paushak ( from AR 2023)
1…New Plant
= New Phosgene derivatives/multi-purpose plant which started contributing in sales from Q4 FY 2022.
=We are pleased to share that we have achieved rated capacities of the new plants while demonstrating
our technical expertise in developing indigenous technology platforms, launching new products and building state of the art plants.
=These new automated plants have also been visited/audited by Global Customers/ Innovators from our targeted segments resulting in more confidence and interest in our technical expertise and is expected to result in future growth opportunities while establishing Paushak as serious global supplier for Phosgene derivatives.
=Our major market like Pharmaceuticals and Agrochemicals are experiencing slow down along with price erosion and intensified competition. This is expected to result in margin pressure in near future.
=However, the new plants have
catalysed our growth while demonstrating our technical capabilities, commitment and our vision to become a global
technology leader in Phosgene and its derivatives while creating niche for us.
2…New products/New technology
=We are working on new technology
platforms while launching new products in near future while investing more to create downstream capacities. We remain
committed to be “Partner of Choice” for our customers while expanding R&D capabilities to support such launches with
addition of more technical resources.
3…Raw material
=Reducing imports significantly and saving foreign exchange.
| Subscribe To Our Free Newsletter |
